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ABSTRACT 
The aim of this thesis is to increase the understanding of the hypothalamic mechanisms that 
are vital for food intake regulation, in particular as it relates to anorexia, and the molecular 
mechanisms underlying myelination and nodal/paranodal domain organization. The majority 
of the thesis concerns the anorectic phenotype of two mouse models for which we have found 
both great similarities and differences pointing to different mechanisms generating similar 
symptoms and neuropeptidergic alterations. This thesis starts with immunohistological and 
electron microscopic investigations of the regulatory effect of the GPI-anchored cell adhesion 
molecule Contactin-1 in myelination in the central nervous system (CNS) and functional 
compartmentalization of myelinated nerves (Paper I). With the help of the Cntn1-KO mouse 
and a Cntn1-KO cross expressing green fluorescent protein in myelin, our analysis revealed 
several novel functions of Contactin-1 in CNS myelination.  These include the demonstration 
of Contactin-1 expression in oligodendrocytes in vivo and its role in regulating neuron-glia 
interactions required for myelin membrane extension and myelination. Further, we found that 
Contactin-1 is essential for the domain organization of myelinated nerves by organizing the 
attachment of the terminal myelin loops to the axon membrane at the paranode. Contactin-1 
is thus a key molecule for forming functional fast propagating high conduction velocity 
myelinated nerves in the CNS. We continue to explore the roles of Contactin-1 in the CNS by 
investigating the anorectic and hypothalamic phenotype of the Cntn1-KO in comparison with 
the anorectic anx/anx mouse (Paper II and IV).  In these two studies involving 
immunohistochemistry and in situ hybridization techniques, we show similarities between the 
two models in the deviation from the wild type expression levels and location of 
hypothalamic neuropeptides (NPY, AgRP, α-MSH/POMC and MCH) important for food 
intake regulation (Paper II). However, further analysis revealed apparent differences with 
regard to the expression of astroglial and microglial markers in the hypothalamic system, as 
well as in the hippocampus (Paper IV). A significant upregulation of markers of astroglial 
and of microglial activation (previously published) was found in the anx/anx hypothalamus, 
indicating an inflammatory reaction. In contrast, the Cntn1-KO mouse displays no such glial 
responses in the hypothalamus. We did however detect increased expression of the microglia 
marker in the hippocampal dentate gyrus of the Cntn1-KO mouse, which we did not see in 
the anx/anx mouse. Based on previous findings associating the anx/anx mouse with a 
mitochondrial dysfunction, we explored the possibility of a reduced metabolic rate of 
hypothalamic neurons (Paper III). Enzymatic assays, ex vivo autoradiography and Western 
Blot of the anx/anx hypothalamus revealed reduced glucose uptake, reduced cellular 
metabolic rate both in basal and ischemic conditions and reduced ATP-turnover. The ratio of 
the metabolic master regulator, AMPK-P/AMPK, was reduced in the anorectic anx/anx 
hypothalamus. Taken together this is indicative of a hypometabolic state in the hypothalamus 
of the anx/anx mouse resembling what is seen during hibernation. The two anorectic mouse 
models have many similarities and many differences making them valuable to further 
understand the food intake regulating systems. By elucidating molecular pathways the data in 
this thesis may in the future yield improved understanding of disorders such as Anorexia 
Nervosa and Multiple Sclerosis. 
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1 BACKGROUND  
Whether concerning the development/plasticity of the hypothalamic systems involved in 
regulation of food intake, or myelination and nodal/paranodal assembly of the optic nerve 
both require a delicate interplay and temporal timing of specific molecular events and 
interactions. These mechanisms are in the present thesis explored in two animal models 
displaying the core features of Anorexia Nervosa (AN); emaciation and starvation due to low 
food intake.  
 
1.1 ANOREXIA NERVOSA 
AN is an eating disorder diagnosed, as other psychiatric conditions, according to among 
others the diagnostic and statistical manual of mental disorders 5th edition, DSM-5, for which 
the diagnosis criteria includes; restriction of energy intake, fear of weight gain despite being 
underweight and disturbed perception of body image [1-3] and with a body mass index below 
19. The prevalence of AN is highest in females aged 15-19 years which corresponds to about 
40% of all AN patients. Overall AN affects around 1,2% of females and 0.3% of males, 
sometime in life [4]. The incidence rate in females is 109,2 per 100 000 per year and the 
incidence in males is about 1 per 100 000 persons –years, found by studies in UK and the 
Netherlands [5-7]. AN has the highest mortality rate among all mental disorders, i.e. 
approximately 10% of those affected die as a consequence of the disorder due to e.g. heart-, 
kidney failure or suicide [8-10]. Another frequently occurring symptom of AN is amenorrhea, 
meaning a loss of menstrual cycle, in women, which is a result of a decrease of reproductive 
hormones. This usually returns with increased weight but not always and then the result may 
be linked to hypothalamic dysfunction [11-13]. Complications of the cardiovascular system 
as a result of decreased contractility and electrolyte imbalances are also common. Besides 
somatic disturbances comorbidity with other psychiatric diagnoses, like depression, anxiety 
and obsessive- compulsive disorders are common [14-17].  
To date the etiology of AN is to a large extent unknown, there are however strong indications 
that the disorder is multifactorial with an interplay between environmental/societal factors 
and a genetic predisposition [18] [19]. The genetic attribution is high, i.e. around 50-70% of 
the background has been traced to additive genetic factors [20-23]. In patients with AN or 
Bulimia Nervosa there have been correlations to disturbances in the hypothalamic-pituitary-
adrenal axis, characterized by hypersecretion of corticotropin-releasing hormone, CRH 
which may lead to cortisol resistance [1, 24-26]. Studies of obesity have gained 
understanding in the mechanisms regulating appetite and stimulation of satiety (see section 
below on hypothalamic regulation of food intake) [27].  
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1.2 ANIMAL MODELS OF ANOREXIA NERVOSA 
While several animal models of obesity are well characterized and used in research such as 
the leptin deficient LepOb/Ob (commonly called Ob/Ob), the leptin receptor deficient LepDb/Db  
(commonly called Db/Db) or high-fat diet induced obese mice, much fewer anorectic animal 
models exist. The complexity of human AN makes preclinical studies of the disorder limited 
to focus on characteristic traits shared with the human version of the disease, such as 
emaciation and starvation [28, 29]. However, these models are still able to generate important 
new information of specific aspects of the disorder such as knowledge about the 
hypothalamic food intake regulating systems in an anorectic condition. Two anorectic mouse 
models are used in the present work; the anx/anx and the Contactin-1 null mutant (Cntn1-
KO) mouse. 
One diagnosis criteria for AN is as stated above a significant weight loss below 85% of 
normal weight for age and height or a body mass index below 18 [30]. A significantly 
reduced body weight is observed from approximately postnatal day (P) 10 for both the 
anx/anx and the Cntn1 mouse, see figure 1.  
 
A.                                                                         B. 
  
Figure 1. A. Body weight curves for Cntn1-KO (black diamonds) vs, WT (grey squares)  (modified 
from Berglund et al. [31]) and B. anx/anx  (black diamonds) vs WT (grey squares) (modified from 
Maltais et al. [32]). 
 
The reduction in body weight results in a severly emaciated appaerance of the mice by P16 
and P21, for the Cntn1-KO and the anx/anx mouse, respectively, when compared to their 
wild type (WT) siblings (Figure 2).  
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A.                                                                       B. 
   
Figure 2. A. Cntn1 (bottom) and WT sibling age P16, B anx/anx (top) and WT sibling age P21. 
The second common nominator between the Cntn1-KO, the anx/anx mouse and patients with 
AN is the reduced and insufficient food intake. This despite that they in all cases, animals as 
well as humans, have full access to food. Maltais et al. showed that the stomach content of 
the anx/anx mouse was significantly reduced already from P5 [32]. The Cntn1-KO mouse has 
a reduced stomach content compared to the WT littermates both for milk and even less with 
solid food (Bergström U and Ranscht B, unpublished data). This mouse is consequently 
helped with assisted feeding twice daily.  
A third parameter shared between AN and the two animal models is the levels of the 
adiposity derived hormone leptin (see below). The levels of leptin is reduced in blood from 
AN patients [33, 34] and is also reduced in the two anorectic animal models in this thesis; the 
Cntn1 and the anx/anx mouse (Figure 3) [32, 35]. 
         A.                                                             B. 
 
Figure 3. A. Serum leptin levels in Cntn1 vs WT mice (unpublished data, Bergström U and Ranscht 
B) and B. anx/anx vs WT mice (modified from Johansen J.E. et al [35]). 
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1.2.1  The anx/anx mouse 
The anx/anx mouse arose spontaneously at the Jackson laboratory (Bar Harbor, ME) back in 
1976 [32]. The anx mutation is an autosomal recessive mutation that arose in the F2 
generation of a cross between an inbred strain derived from crossing M.m.poschiavinus and 
an inbred Swiss strain with DW/J. The mouse was brought to Karolinska Institutet by Prof. M 
Schalling, in the mid 90’ies and has been bread independent of the Jackson line since then. 
The mutation is maintained on the B6C3H-a/a F1.background and was mapped to a 0.2 cM 
interval on mouse Chromosome 2 [32, 36]. As explained above the anx/anx mouse eat 
significantly less than their WT siblings already from P5. Subsequently the mouse becomes 
emaciated and dies in a rather lethargic state around postnatal day 21. The anx/anx mouse is 
bread from heterozygote parents as the anx mutation is too detrimental and lethal before 
breeding can begin.  
Several papers have shown aberrances in neuropetidergic and -transmitter systems in the 
hypothalamus that are central for regulation of food intake [37-50]. Nilsson et al showed up 
regulation of a marker for microglia selectively in hypothalamic areas involved in food intake 
regulation [45]. Microarray studies of the anx/anx hypothalamus by Mercader et al and 
Lachuer et al. revealed a cachectic and inflammatory profile, respectively [51, 52]. Up 
regulation of several microRNAs in the hypothalamus was shown as well as increased 
expression of the Ntrk3 gene, coding for a receptor for Neurotrophic Tyrosine Kinase, 
Receptor, Type 3 [53]. In addition to the hypothalamus, increased proliferation and apoptosis 
was documented in the dentate gyrus part of the hippocampus of these mice [54]. Lastly, it 
has been shown that a gene in the interval were the anx-mutation is located called 
NADH:ubiquinone oxidoreductase complex assembly factor 1, (Ndufaf1) is down regulated 
in the anx/anx mouse [36]. This gene is an assembly factor for the first complex (C) in the 
oxidative phosphorylation system in the mitochondria [55] (Figure 4). A down regulation of 
this gene thus results in a reduced capacity of CI and increased production of reactive oxygen 
species (ROS) [36].  
 
Figure 4. The mitochondrial oxidative phosphorylation system; Complex I to V with the enzymes 
abbreviated analyzed in Paper III. NADH: ubiquinone oxidoreductases (NQR): succinate 
dehydrogenase (SDH), succinate: cytochrome c reductase (SCR), cytochrome C oxidase (COX), 
ATPS: ATP synthase.  Adapted from general textbooks. 
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1.2.2  The Cntn1-KO mouse 
The Cntn1-KO mouse was created in the Ranscht laboratory by Dr. Eric O. Berglund through 
insertion of a neomycin resistant cassette into exon 3 of the Contactin-1 gene thereby 
disrupting the normal functions of the protein [31]. The gene construct was then transferred to 
embryonic stem (ES) cells by homologous recombination. The ES clones were subsequently 
transferred into blastocysts creating chimeras. The mouse is maintained on either a mixed 
129SVJ 3x C57Bl/6 3 x Black Swiss or a pure C57Bl/6 background and no developmental, 
molecular or phenotypic differences are observed between the lines. The Cntn1-KO mouse is 
born identical to the WT littermates, however by P8 a reduced body weight and tremors start 
to become apparent. They are fed twice a day from P10 and given subcutaneous saline 
injections and in addition they had free access to milk and chow. The characteristic 
phenotypes develop gradually with ataxia and anorexia as the major traits, but also a failure to 
rectify to upright when turned on to the back. The Cntn1-KO mouse dies in a very emaciated 
state between P16-19, despite given nutritional supplementation twice.  The Cntn1-KO 
mouse is born from heterozygote parents, as homozygote breeding is impossible due to the 
detrimental phenotypes and lack of survival.  
In the cerebellum is Contactin-1 localized to the synaptic contacts between Golgi and granule 
cells and in the Cntn1-KO mouse this results in a decrease of both pre- and postsynaptic 
GABAergic proteins in these cells [56] as well as deformed cerebellar glomeruli 
(unpublished Bergström, U.). The Cntn1-KO mouse also has a reduction in neurite outgrowth 
from isolated dorsal root ganglion and cerebellar granule neurons, implicating specifically 
Contactin-1 to be involved in neurite outgrowth [57, 58]. Loss of Contactin-1 in myelinated  
nerves disrupts the paranodal attachment  sites  between myelin and the axon and slows down 
the propagation of compound action potentials along the nerve [59]. Finally, the Cntn1-KO 
has been utilized to analyze the nodal and paranodal complexes of centrally myelinated 
nerves [60-63]. 
 
1.2.3 Contactin  
The Contactins are a family of immunoglobulin cell adhesion molecules expressed 
exclusively in the nervous system The other Contactin family members are Contactin-2 
(TAG-1), Contactin-3 (BIG-1), Contactin-4 (BIG-2), Contactin-5 (NB-2) and Contactin-6 
(NB-3)[64, 65]. Contactin-1 was first to be named Contactin and occurs in early publications 
as only Contactin or F11 (chicken) [66] or F3 (mouse) [67] or Gp135 (human) [68]. At the 
amino acid level, human Contactin-1 is 78% identical to chicken Contactin-1/F11 and 94% to 
mouse Contactin-1/F3 [69]. Both Contactin-1 and Contactin-2 have been linked to important 
developmental events involving axon guidance, myelination, neuronal cell adhesion, 
migration and neurite out growth [70, 71]. The Contactins are characterized as cell surface 
glycoproteins with six immunoglobulin-like domains and four fibronectin-like regions and 
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are linked to the cell membrane through a glycosylphosphatidylinositol (GPI)-anchor 
[72],[73]. In myelinated nerves in the central nervous system (CNS) and the peripheral 
nervous system (PNS), Contactin-1 is found in at the paranodes located on each side of the 
node of Ranvier.   The axonal Contactin-1 interacting in cis with Contactin associated protein 
-1 (Caspr-1) on the axonal side and in trans with neurofascin -155 on the glia side [59].  In the 
CNS, Contactin-1 is in addition localized at the nodes of Ranvier and on the oligodendrocytes 
where it regulates not only paranodal domain organization but also myelination and nodal 
structure and function [74].  Contactin-1 regulates the cerebellar granule cell migration, and 
guidance of granule cell axons and dendritic projections from granule and Golgi cells [31]. 
The interaction between Contactin-1 and Caspr is essential for the latter’s release from the 
endoplasmic reticulum and transport to the plasma membrane [75]. Caspr is a transmembrane 
protein that contains a cytoplasmic region that can interact with other molecules and anchor 
the complex to the cytoskeleton. Contactin-1 is localized to synapses and essential for 
targeting Caspr to synapses in the hippocampus and affect the proper distribution of receptor-
type protein tyrosine phosphatase beta (RPTPß) expressed by neurons and glia cells [76]. 
However, Contactin-1 role in synaptic plasticity is independent of its association with Caspr 
[77]. Finally, Contactin-1 has most recently also been associated in tumor invasion and 
metastasis [78] and was found to interact with Caspr2 [79] which may be linked to autism 
[80, 81]. Interestingly, genetic studies have found associations between genes related to 
contactins and AN [82, 83]. 
 
1.2.4 Other animal models of anorexia 
In addition to the Cntn1-KO and the anx/anx mouse models for AN there are a few other 
rodent models displaying various phenotypes resembling traits in the human condition AN, 
most commonly the low food intake and the emaciation. The activity-based anorexia (ABA) 
mouse/rat model possess the key characteristics of AN, mainly hyperactivity and reduced 
food intake. The anorexia of the ABA rodents is induced by food restriction and introduction 
of an exercise wheel into the cage. When reinstating unrestricted access to food, when the 
wheel still is present, they continue to prefer running instead of eating. This leads continued 
weight loss until death. If the wheel is removed when food is again unrestricted the weight is 
normalized [84, 85]. Another mouse model that also becomes hypophagic and hyperactive is 
the dopamine deficient (DD) mice. These mice lack the dopamine-synthesizing enzyme, 
tyrosine hydroxylase, in dopaminergic neurons.  Around postnatal day 34 this mouse dies as a 
result of starvation [86]. Both mice and rats centrally injected with brain derived neurotrophic 
factor, BDNF, have been found to induce feeding suppression [87] and weight loss [88]. 
Interestingly, variants of the BDNF gene have been associated with AN [89]. Adult ablation 
of AgRP neurons also results in anorexia [90] while neonatal ablation of the same neuronal 
population has no body weight phenotype [91]. Anorexia is furthermore observed in mice 
after ablation of Glut4 neurons in the hypothalamus [92] and with hypothalamic inhibition of 
AMPK food intake is reduced [93, 94].  
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1.3 HYPOTHALAMIC REGULATION OF FOOD INTAKE 
Energy homeostasis refers to the processes that govern the balance between the ingested 
energy from food, the input, and the cellular energy expenditure, the output, by the process of 
basal metabolism and physical activity (increased metabolism) [95, 96]. A positive energy 
balance indicates a higher energy intake than what is consumed by energy expenditure, and 
will over time result in weight gain when the energy is stored mainly as fat. Negative energy 
balance is a result of lower energy intake than what is consumed e.g. during fasting or 
starving. There are several clinical manifestations that affect this delicate balance to maintain 
a healthy energy balance, such as diabetes, obesity and the reverse malnutrition, anorexia and 
cachexia [97, 98]. The hypothalamus is the area of the brain that is central in the coordination 
of the regulation of food intake and thus provides potential therapeutic targets both 
concerning anorexia and obesity [99-103].   
 
1.3.1 Anatomy and neurochemistry of the hypothalamus 
The hypothalamus is part of the diencephalon and is involved in mediating endocrine, 
autonomic and behavioral functions. The hypothalamus controls hormone release from the 
pituitary gland, temperature, food intake, reproduction and the circadian rhythm [104]. The 
center for regulation the food intake is a cluster of cells located in the mediobasal 
hypothalamus, the Arcuate nucleus (Arc) [105, 106]. 
The Arc is located adjacent to the third ventricle and the median eminence where the blood-
brain-barrier is more permeable, which makes these neurons susceptible to hormonal 
variations originating from the periphery. The Arc contains neuroendocrine neurons 
(ventrolateral Arc) and centrally projecting neurons (ventromedial) [105-108]. This thesis 
focus on the centrally-projecting neurons projecting to the paraventricular nucleus (PVN) and 
the lateral hypothalamic area (LHA), but the Arc also establish additional connections with 
other hypothalamic areas well as extra-hypothalamic areas including the medial preoptic area 
(MPO) and the dorsomedial hypothalamus (DMH). One of the two main Arc neuronal 
populations projecting centrally is the neuropeptide Y (NPY) and agouti-related protein 
(AgRP) expressing mostly GABAergic neurons mediating orexigenic signaling (increase 
food intake) [109]. The second Arc population is the pro-opiomelanocortin (POMC), and 
cocaine- and amphetamine-regulated transcript (CART) expressing glutamatergic neurons 
mediating anorexigenic signaling (decrease food intake). In addition to PVN and LHA 
projections the Arc AgRP/NPY and POMC/CART neurons interconnect with each other to 
regulate their neuronal activity and downstream effects and to ensure quick feedback in 
response to energy demand [42, 110-112]. There is at least one other GABAergic neuronal 
population in the Arc negative of AgRP or POMC, which is mildly involved in post-weaning 
feeding and projects directly to PVN [113]. 
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The afferent inputs to the PVN include inputs form NPY/ AgRP positive neurons in the Arc 
regulating energy intake and inputs from the hippocampus regulating stress responses [114, 
115]. Some efferent axons from the PVN project to median eminence at the base of the brain 
where neurosecretory nerves release hormones as part of the hypophyseal portal system 
(system of blood vessels in the brain connecting the hypothalamus with the anterior pituitary) 
resulting in hormone release regulation [115]. Other PVN axons project also to other brain 
regions as well as to the brainstem and spinal cord affecting the sympathetic system 
maintaining the cardiovascular homeostasis [116]. 
 
1.3.2 Postnatal development of the AgRP/NPY system 
The Arc AGRP/NPY system involved in food intake regulation develops postnatal in mouse 
[110] and rat [117]. In mice, the first Arc projections the DMH are established at postnatal 
day 6 (P6), while but the projections to the PVN develops significantly later with the first 
mature connections established around P8 to P10 [110]. 
Different mouse strains have different developmental timelines and do not 100% correlate to 
each other molecular expression patterns [118-124] it is thus of importance to reflect on the 
time factor in developmental studies [125, 126]. In general the brain of newborn mice is more 
immature at birth and developmentally corresponds to human fetuses at the beginning of the 
third trimester of pregnancy [127]. However, the projections of human food intake regulatory 
pathways develop predominantly after birth [128] but the cell clusters representing the 
different hypothalamic areas are formed during later prenatal development. 
The Arc projections are highly modifiable in mice pups and are affected by environmental 
factors coming from peripheral hormonal changes and genetic factors from within the 
AgRP/NPY and POMC/CART neurons [129-132]. This is observed in diet- induced obese 
rats where the Arc projections are permanently damaged [133]. 
In addition to the direct effect on food intake (see below), leptin is suggested to play an 
important role during postnatal development by regulating axonal outgrowth of both 
AgRP/NPY and POMC/CART neurons to target areas in the hypothalamus [110]. The 
rationale behind this is the leptin level peak during postnatal development that coincides with 
the Arc axonal outgrowth and the fact that this early the leptin levels doesn’t correspond to 
the levels of adipose tissue. Leptin may during the postnatal development of the food 
regulatory pathways in the hypothalamus function as a growth factor promoting axonal 
outgrowth.  
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1.3.3 Food intake regulatory hormones from the periphery 
Energy homeostasis is regulated via peripheral signals from both adipose tissue and the 
gastrointestinal tract penetrating the more permeable blood-brain-barrier (BBB) next to the 
median eminence and binding to receptors on the AgRP/NPY and POMC/CART neurons in 
Arc (Figure 5), and via the vagus nerve projecting to the brain stem. 
Leptin is a hormone predominantly released from adipose tissue in response to food intake 
and the levels in blood correlates with the amount of adipose tissue. The hormone is 
transcribed from the obese Ob-gene and actively influences energy homeostasis. Circulating 
leptin enters the brain via the BBB and its receptor, the Ob-Rb, which is widely expressed in 
the hypothalamic regions; Arc, VMH, DMH, LHA and MPO [134-136].  Leptin binds to its’ 
receptor which lead to downstream signaling involving activation/phosphorylation of STAT3 
and in the orexigenic NPY/AgRP neurons it inhibits the activity, however, leptin activates 
anorectic POMC/CART neurons [105, 137]. Under conditions with low amounts of 
circulating leptin, like fasting, the orexigenic pathway is switched on and under the reverse 
conditions the anorexic pathway is switched on [138].  
Ghrelin is the only known orexigenic hormone and was first discovered to be produced in 
the gastrointestinal tract but have been found to be produced in almost all tissues including 
Arc (NPY/AgRP neurons) in the hypothalamus together with its’ receptor, growth hormone 
secretagogue receptor (GHSR) [139, 140]. Ghrelin can be transported bi-directionally across 
the BBB and has an antagonistic effect to action of leptin on the NPY receptors and correlates 
reversely to the levels of insulin, resulting in increased activity of the NPY/AgRP 
neurons.[141] Ghrelin expression will therefore lead to increased food intake [142] 
Insulin is secreted from the pancreas and positively correlates with long-term energy balance 
but is primarily regulating blood glucose levels. Insulin enters the brain via the BBB and the 
concentration of insulin inside the brain is proportional to the serum levels. In the 
hypothalamus, insulin acts as an anorectic signal reducing food intake and body weight [143]. 
Insulin signals via a cell-surface insulin receptor widely expressed in the brain but 
particularly in hypothalamic Arc nuclei involved in food intake but also in DMH, PVN and 
PVN [144, 145]. Insulin signaling results in inhibition of the orexigenic NPY/AgRP neurons 
and activation of POMC/CART neurons [146]. Besides regulating the neuropeptidergic 
expression in the hypothalamus regulating food intake, both insulin and leptin signaling also 
includes opening or activation of the ATP dependent potassium channel, KATP, resulting in 
hyperpolarization and reduced metabolic activity of the neuron [147, 148]. 
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Figure 4. Schematic illustration of the Arc with POMC/CART and AGRP/NPY neurons and their 
responses to the peripheral hormones leptin and insulin. 
 
1.4 GLIA CELLS 
The glia cells of the central nervous system are divided into two types; the macroglia and the 
microglia. During the development macroglia cells consists of astrocytes and 
oligodendrocytes but in adult there is a fourth type of glia cell, the adult oligodendrocyte 
precursor cells expressing NG2 [149]. Astrocytes and oligodendrocytes together with neurons 
are generated from neuro-epithelial stem cells located in the ventricular zone surrounding the 
ventricles [150, 151]. The origin of the microglia is myeloid, the same as monocytes but 
where the microglia precursor cells reside and differentiate into microglia is not fully 
understood but suggestions are that they are the meningeal macrophages or circulating blood 
monocytes [152].  
 
1.4.1 Astrocytes 
Astrocytes contributes to the formation of the BBB [153]. They associate with 
oligodendrocytes and myelin, and interacts directly with neurons by supporting synapse 
formation and maintenance [154]. Astrocytes are further implicated in neurotransmitter 
reuptake [155]. In the hypothalamus, the attaching strength of the excitatory synapses in the 
PVN is regulated by astrocytes [156], and in the hippocampus they are found to affect both 
excitatory and inhibitory synapses [157]. Depending on their activity the astrocytes attain 
different conformation changes the spherically bushy variant (activated), the less bushy form 
(inactive), and the very elongated, non-excitable version (Muller cells in the retina and 
Bergmann glia in the molecular layer of cerebellum) [158]. When compared between species 
the complexity and size increases with increased complexity of the brain [159].  
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1.4.2 Oligodendrocytes 
Oligodendrocytes provide insulation and results in compartmentalization of the axons 
resulting in rapid impulse propagation [160]. Oligodendrocytes also provide a trophic support 
to the axons in the paranodal and juxta-paranodal regions [161-164]. The 
compartmentalization divides the myelinated axons into the node of Ranvier where the 
sodium channels, Nav1.2 and Nav1.6, are clustered. The node of Ranvier is flanked by two 
paranodes at which the myelin sheaths are attached through septate-like junctions, which 
create a tight barrier between the nodes of Ranvier and the juxtaparanode underneath the 
myelin. Paranodes serve as a conduit between the axon and the myelin, and to segregate the 
sodium channel clusters at the nodes from the potassium channels at the juxtaparanodes to 
enable saltatory nerve conduction. Neural/glial antigen 2, NG2, is commonly used to identify 
the oligodendrocyte precursor cells which are immature glial precursor cells that have the 
ability to differentiate into oligodendrocytes [165]. Adenomatous polyposis coli, APC, can be 
used to identify fully mature oligodendrocytes [166]. Ankyrin-G can be used as a marker of 
the node of Ranvier [167].   
 
Myelination is the process under which the axons of nerve cells are being wrapped and 
insulated by myelinating glial cells, Schwann cells in the periphery and oligodendrocytes in 
the central nervous system. The role of axon myelination is to enable saltatory propagation of 
nerve impulses thereby increasing action potential velocity [168]. 
Myelin is an extension of the oligodendrocyte plasma membrane, which wraps an axonal 
segment in a spiral fashion and forms a condensed multi-lamellar sheath, which is typically 
identified in electron microscopy (EM) cross sections as a dense profile [169, 170]. Myelin 
oligodendrocyte glycoprotein, MOG, is important for structural integrity of the myelin sheath 
and expressed late by oligodendrocytes [171]. Myelin basic protein, MBP, and proteolipid 
protein, PLP are also expressed within the myelin and maintain the correct structure of 
myelin [172, 173].  
Large axons (>1um) are first myelinated with compact myelin and will receive more layers of 
myelin compared to thinner axons. The ratio between axonal diameter and myelinated fiber 
diameter, the g-ratio, has frequently been used as a measure for myelination during 
development [174]. However, even smaller axons (>0.4um) in the optic nerve and cortex are 
myelinated but with thinner sheaths. 
The physical myelination as such does not preserve axonal functions and survival but the 
myelinating oligodendrocytes provide molecular interactions that ensure axonal support. The 
axonal thickness may also increase with increased myelination possibly due to signals 
provided by molecular axon-glia interactions. This axon-glia interactive signaling includes 
axonal spiking activity because ATP release [175].  
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Multiple sclerosis (MS) is probably the most well known demyelinating disease where the 
insulating myelin covering the fast conducting axons in the brain and the spinal cord are 
damaged resulting in disrupted neuronal communications. Myelin-related dysfunction, 
however, has also been connected to schizophrenia [176, 177], depression, autism, Alzheimer 
disease and Huntington chorea [178]. 
 
1.4.3 Microglia 
The function of the microglia is to monitor the well-being of their environment and to 
respond to changes by protective mechanisms or assist in immune reactions [179]. Activated 
microglia release cytokines and function as immuno-and neuromodulatory messengers acting 
on the astrocytes and neurons in the area [180]. The morphology of activated microglia is 
following a highly characteristic pattern with the base line of the resting non-pathological 
microglia with small soma and moderately ramified (dendritic processes), activated microglia 
with large round soma and hyper ramified/ bushy processes, continuing activation lead to 
retraction of processes which reduces the ramification but still large round soma, then in 
parallel there is a separate type of activated microglia with rod shaped large soma with 
retracted processes [181]. Chronic psychological distress has been found to induce microglia 
activation in affected brain regions [182, 183]. This is particularly observed in Alzheimer’s 
[184] and Parkinson’s disease [185] but also in association with depression [186] and autism 
[82]. Microglia is also contributing to postnatal remodeling of synapses [187, 188]. 
  
  25 
2 THESIS OBJECTIVES 
The overall goal of this thesis is to increase the knowledge about the hypothalamic systems 
regulating food intake in anorectic conditions and to explore the role of Contactin-1 in nodal 
paranodal assembly and the myelination process.  
 
The specific aims of the studies included in the thesis are: 
Paper I To study the developmental role of Contactin-1 in nodal and paranodal 
assembly and in the myelination process, using the optic nerve as a model for 
myelinated nerves in the central nervous system.  
 
Paper II To compare neuropeptidergic expression in the hypothalamus of two anorectic 
mouse models, the Cntn1-KO and the anx/anx mouse, and food deprived mice. 
 
Paper III To investigate the activity of the hypothalamic area in the anorectic anx/anx 
mouse. 
 
Paper IV To compare the expression of microglia and astroglia markers in the 
hypothalamus and hippocampus of two anorectic mouse models, the Cntn1-KO 
and the anx/anx mouse.   
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3 MATERIALS & METHODS 
 
3.1 ANIMALS (PAPER I-IV) 
All experimental procedures involving mice were approved by the Institutional Animal Care 
and Use Committee of Sanford-Burnham Prebys Medical Discovery Institute (La Jolla, CA) 
and by the local ethical committee, Stockholms norra djurförsöksetiska nämnd, (Stockholm, 
Sweden). All the animals were housed in animal facilities on 12hr light to dark cycles at a 
constant 25°C temperature. Food and water was supplied ad libitum and they free to suckle 
milk from the mother.  
Cntn1-KO mice were created in the Ranscht laboratory by Dr. EO Berglund [31]. Contactin 
exon 3 was disrupted by insertion of a neomycin–resistance cassette the mutated allele was 
transferred to embryonic stem (ES) cells by homologous recombination. The ES clones were 
then transferred into blastocysts creating chimeras. The Cntn1-KO mouse is born from 
heterozygote parents, as homozygote breeding is impossible due to the detrimental 
phenotypes and lack of survival. Cntn1-KO mice were genotyped by PCR using forward and 
reverse primers covering exon3 of the Cntn1 gene and an additional primer inside the neo 
cassette. PCR generates two DNA fragments, which were separated by agarose gel 
electrophoresis for size identification. The mutated fragment appeared as a fragment of 369 
nucleotides, while the WT fragment was 166 nucleotides. The backgrounds of the Cntn1-KO 
mouse used for the experiments were a mixed (129SVJ × C57Bl/6 × Black Swiss) and a 
purebred line (C57Bl/6). Both lines display an identical phenotype and molecular patterns of 
marker expression. Phenotypic characterization of the Cntn1-KO mouse was based on the 
reduced body weight compared to WT littermates (fig 2a) and the ataxia. 
To aid identification of Contactin-1 in the oligodendrocytes during the development (Paper 
I) we crossed the Cntn1 heterozygotes with the transgenic mice expressing GFP (green 
fluorescent protein) under the PLP (myelin proteolipid protein) promotor provided by Dr. W. 
Macklin [189]. PLP is the major intrinsic membrane protein of CNS myelin and is expressed 
in oligodendrocytes [173]. 
The anorexia mouse model the anx/anx mouse harbors a spontaneous mutation that arose in 
the Jackson laboratory in 1976 [32]. The mutation is maintained on the B6C3H-a/a 
F1.background. The animals used in the thesis were obtained by Dr. M Schalling, Karolinska 
Institutet and maintained there as a separate colony with sibling breeding. The anx gene was 
mapped by Dr. J Johansen and colleagues to a 0.2 cM interval in the nonagouti (a) locus on 
mouse chromosome 2 [38]. The anx/anx mouse is genotyped using simple sequence length 
polymorphism (SSLP) markers mapped to the sub-chromosomal region to which the anx 
mutation is located on chromosome 2. The primer pairs were chosen around simple repeats 
located in the anx mutation interval, giving rise to a slightly larger anx-product, which 
subsequently can be differentiated by gel electrophoresis. The anx/anx mouse was 
phenotypically characterized by reduced body weight from postnatal day 8-9 and 
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deteriorating appearance by age. All animals are housed in a 12hr light to dark cycle with 
food and water provided ad libitum. 
 
3.2 IMMUNOHISTOCHEMISTRY (PAPER I, II AND IV) 
Immunohistochemistry (IHC) is a method used to visualize proteins/peptides (antigens) of 
interest at their natural location within the tissue by the use of antibodies that recognize and 
bind to specific antigens. Those antigen specific antibodies are called primary antibodies, and 
the Fab’ fragment of these binds to the antigen. To detect this binding a secondary antibody is 
used in which the Fab’ fragment is specific to the Fc’ part of the primary antibody which is 
specific for the species that the primary antibody was generated in, i.e. rabbit, mouse and rat 
etc. The secondary antibody is of a different species i.e. goat or donkey, and can be labeled 
with a fluorescent label (i.e. FITC or Cy3) or an enzyme reporter (i.e. horseradish peroxidase 
[HRP] or alkaline phosphatase [AP]). Immunohistochemical protocols are dependent on 
several parameters such as tissue fixation, detergent type and concentration, time, 
temperature and antibody affinity.  
 
3.2.1 Fixation of tissue 
The fixation procedure is an important part of IHC and the purpose of fixation is to cross link 
the molecules so they remain at their natural location or at least as a frozen moment in time. 
However, this crosslinking can result in hidden or exposed epitopes to which the Fab region 
of the primary antibody is specifically binding. Choice of fixative is therefore crucial for IHC. 
This is highlighted in Paper I.  
For Paper I Optic nerves were dissected out fresh from different ages and then placed in 
different fixative for a variation of times following a carefully established protocol to be able 
to successfully visualize different locations of the Contactin-1 protein. More specifically see 
information regarding staining optimization in Table 1 in [74]. However, in general 4% 
paraformaldehyde (PFA) was used as the primary fixation and methanol was used to extract 
lipid layers in order to expose Contactin-1 epitopes otherwise hidden. 
For immunohistochemical evaluation of other brain regions (Paper II & IV) Cntn1-KO and 
WT animals were perfused with 4% PFA in 0.1M phosphate buffer pH 7.4 at 25C. Brains 
rapidly dissected under a dissection microscope and immersed in ice-cold fix for 4 hrs before 
changing into 30% sucrose in 0.1 M phosphate buffer pH 7.4. After overnight immersion in 
sucrose the brains are further dissected, and snap frozen using 2-methyl-butane on dry ice. 
For immunohistochemical evaluation of the anx/anx brain perfusion was performed with a 
mixture of PFA and picric acid as described by Pease (1962) [190] and Zamboni and De 
Martino (1967) [191]. The brains were rapidly dissected out and immersed in fixative for 90 
min then put in 10% sucrose in 0.1M phosphate buffer pH 7.4, overnight in 4C. Tissue was 
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then either snap frozen using CO2 (gas) or 2-methyl-butane (isopentane) on dry ice and cut in 
a cryostat at 6-14µm thickness. 
 
3.3 IMMUNOHISTOCHEMICAL LABELING  
The result of the IHC is only as good as the specificity of the primary and secondary 
antibodies, and this can vary. If antibodies are constructed against an epitope that is hidden 
the antibody will not bind, and will therefore require an antigen retrieval protocol. In general, 
antibodies created in animals usually give stronger signals, as animals generate several 
different antibodies against the antigen (polyclonal). This is to be compared to antibodies 
generated as monoclonal by hybridoma cells. 
In short all the IHC protocols involved binding of primary antibodies with Fab’ specificity to 
the antigen expressed in the tissue. For some protocols we reduced unspecific binding by 
adding bulky proteins competing with the unspecific binding sites (from donkey serum, goat 
serum or bovine serum albumin). The Fc’ site on the primary antibody is representing the 
species specificity in which the antigen was produced. The secondary antibody has an 
identifiable “tag” at the Fc’ side and the Fab’ side has specificity to the species presented on 
the primary Fc fragment. With this method one can identify and localize specific peptide 
sequences in the tissue. The “tag” on the secondary antibody can be a horse-radish peroxidase 
(HRP) tag as in the case of tyramide signal amplification where it is used to catalyze the 
deposition of fluorescent labeled tyramide (TSA technique, Paper II and IV). Another “tag” 
on the secondary antibody can be a directly bound fluorescent molecule (Paper I and II). A 
third one is biotin to which the avidin-biotin-peroxidase complex (ABC) can bound and 
amplify the 3,3'-diaminobenzidine signal (DAB, a substrate for peroxidase) (Paper I). In 
Paper I the different fixation techniques visualized different immunolabeling as the different 
techniques exposed different epitopes .For example, the GPI anchor of the Contactin-1 
protein is easily extracted unless crosslinked, however, when it is covered by myelin as in the 
paranodes, Contactin-1 is more resilient to extraction by methanol.  
To identify myelin in whole brain, by using antiserum against myelin basic protein (MBP), 
we decided to use free-floating sections in order to increase penetration of the antibody, for 
all others section they were mounted on glass slide. The other method of myelin detection 
was the Gallyas histochemical staining which is a silver nitrate stain that specifically binds to 
myelin under certain pH and chemical solution [192].  
To validate IHC protocol and primary antibodies one can use tissue or cells to which the 
antigen for the primary antibody is absent, e.g. tissue from knockout animals. Another 
approach is to incubate the primary antibody together with an excess of the corresponding 
peptide. Performing the protocol in absence of the primary antibody can be used as validation 
of secondary antibodies. The localization of antibody binding can also be validated with in 
situ hybridization of the corresponding mRNA.  
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The main difference in IHC techniques used in Paper II and IV compared to Paper I is the 
use of picric acid combined with PFA in the fixation, and the usage of the TSA technique for 
the labeling [193]. The fixation proved to enhance Iba1 and GFAP staining, and the use of 
TSA technique enhanced any antibody detection and a lower concentration of both primary 
and secondary antibodies can be used. In Paper II and IV the sections were thicker which 
yields a higher density of cells and makes penetration more important, which was possibly 
achieved by the addition of the methanol in the ready to mix PFA solution.  
 
3.4 IN SITU HYBRIDIZATION (PAPER II) 
In situ hybridization (ISH) in tissue provides a direct visualization of the spatial location of a 
specific mRNA/DNA/microRNA sequence. In Paper II (ISH) was utilized to locate and 
compare Arc mRNA expression of NPY, AgRP, POMC and a-MSH with antisense oligo 
probes (complementary to mRNA sequence).  The specific method used for this in situ 
hybridization was developed by Schalling et al [194] and shortly includes incubating the 
probes in an hybridization buffer containing salmon sperm as blocking in a humid 42 degree 
chamber, and then washed and dried before dipped in a nuclear emulsion containing silver 
crystals followed by developing in Kodak D19 and fixed by Kodak 3000.  The probes were 
radioactively labeled at the 3’-end and after hybridizing the probes to the brain sections on 
slides the anatomical location of the radioactivity is detected onto a film. To quantify the 
density of the silver grains representing the hybridized probe, the images were processed 
using a 256 grey scale (black= 256 and white=0) creating a mean pixel density. The mean 
pixel density was converted to relative optic density (ROD) to represent the density of the 
silver grains on processes brain sections [195].  
The pros of using radioactive in situ probes over fluorescent labeled probes is the increased 
sensitivity of the method, i.e. a lower copy number of target mRNA can be detected,. The 
radioactivity of the labeled probes has however a more limited shelf life, compared to 
fluorescently labeled probes [196]. Radioactivity detection can be scattered when the 
radioactivity decline and this can affect the resolution of the technique.  
 
3.5 ELECTRON MICROSCOPY 
To be able to study ultra-structures in the nodes of Ranvier, paranodes with their septate like 
junctions and myelin processes and axon-glia interactions in greater magnification and with 
higher resolution, we used electron microscopy on optic nerve tissue. Electron microscopy 
allows recognition of the paranodal septate like junctions that are essential for the 
establishment of the discreet nodal, paranodal and juxtaparanodal in Paper I. 
The preparation of the tissue for the electron micrographs were following the previously 
described protocol [197]. In short, transcardial perfusion with a mix of 2% formaldehyde and 
2% glutaraldehyde followed by a post fixation procedure involving uranyl acetate to enhance 
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membrane contrast and to stabilize membrane structures including gap junctions [198] and 
myelin [199] and the finally embedded in an epoxy embedding compound and the ultra-thin 
sections were stained with a solution containing lead. The samples are viewed in an electron 
microscope in vacuum. The cellular details revealed by electron microscopy compared to 
regular confocal imaging are far more detailed and generating images, electron micrographs 
with higher magnification up to 10, 000,000 times (regular up to 2000x).  
 
3.6 WESTERN BLOT (PAPER II & III) 
Western blot (WB) is used to investigate the levels of protein expression in homogenate or 
extract from tissue/cells. The basis for WB is separation of proteins according to size on, 
most commonly, denaturizing sodium dodecyl sulfate poly acrylamide gel electrophoresis 
(SDS-PAGE), which subsequently are transferred by to a membrane immobilizing the 
proteins that then can be further analyzed using immunological detection of specific proteins.  
Before running the proteins on the SDS-PAGE gel, they are denatured by the use of reducing 
agent (ß-mercaptoethanol) and the anionic detergent, SDS, which maintains the denatured 
conformation of the proteins by binding to the polypeptides evenly. The bound SDS creates a 
negatively charged molecule with charge approximately relative to its’ size, which can be 
separated on the SDS-PAGE gel running towards the positive electrode.  In Paper I WB was 
performed on whole mouse brains after protein extraction using RIPA buffer to maintain the 
integrity of the immunoreactivity of the membrane bound proteins, and the method was used 
on whole brain in order to detect levels of myelin. In Paper IV WB was performed on 
isolated hypothalamus and the lysis buffer used contained HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) (standard buffer), to detect protein levels of AMPK un-
phosphorylated and phosphorylated and two glucose transporters, Glut1 and Glut4. 
As WB provides knowledge on protein level in a sample it is just a relative method of protein 
size as it depends on the amount of bound SDS and if a protein has a greater hydrophobic 
content, like membrane proteins the amount of bound SDS varies significantly [200]. 
. 
3.7 EX VIVO AUTORADIOGRAPHY (PAPER III) 
Because of the small size of various brain regions in the anx/anx mouse functional magnetic 
resonance imaging, fMRI, is not possible. Instead we in Paper III used ex vivo 
autoradiography in order to investigate the metabolic activity of in particular the 
hypothalamus of these mice. Autoradiography as such is just an image on an x-ray film, 
which has been exposed to radioactive emissions, in our case from radioactive glucose taken 
up by the brain cells.  In short our assay was performed by injections of radioactively labeled 
Deoxy-D-(DD)-glucose and investigating the uptake as a measure of incorporated 
radioactivity. To normalize the glucose uptake the animals were fasted prior to injection of 
radioactive glucose and the injected glucose was taken up by the cells for 45 min before the 
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brains were rapidly dissected out and frozen. The cryosectioned brain was exposed to 
phosphor-imaging plates and the results were analyzed as pixels per area in the corresponding 
regions of interests (ROI), hypothalamus, motor cortex, and thalamus. The ROI data was 
normalized with the activity of the radioactive glucose, the radioactivity levels in the serum 
and the levels of blood glucose. The injected glucose makes up only a very small portion of 
the total blood glucose and will thus not add to these levels. In addition, the form of glucose 
injected, DD-glucose is not metabolized further in glycolysis, which therefore makes it ideal 
for studying uptake of glucose into tissues [201]. 
 
3.8 ENZYMATIC ACTIVITY ASSAYS (PAPER III) 
Enzymatic assays can be used to quantify various substrates in a suspension and are based on 
measuring the activity of specific enzymes, i.e. how much substrate per unit that is converted 
over time or the reaction speed of which an amount of substrate is converted. The enzymatic 
activity of the major complexes of the oxidative phosphorylation (OXPHOS) were in Paper 
III analyzed spectrophotometrically, and the activity was normalized to the activity of citrate 
synthase (CS) a mitochondrial matrix enzyme often used as a measure of mitochondrial 
disruption during the experiment [202]. CS acts as pace maker and mitochondrial marker 
[203]. Enzymatic assays were further used to analyze the levels of metabolites (Cr, PCr, ATP, 
Glucose-6-P and lactate) in Paper III using fluorometry. By adding specific enzymes 
(pyruvate kinase, creatine phosphokinase, hexokinase, glucose-6-phosphate dehydrogenase 
and lactate dehydrogenase) and subsequently measuring the fluorescence that is linked to the 
production of the downstream metabolites NAD(P)H. The methods used for the enzymatic 
assays for the mitochondrial OXPHOS were developed by Wibom et al [204] for muscle 
analysis and modified by using a different homogenization buffer containing sucrose, EDTA 
and BSA (Paper III). The method in short involved isolation of mitochondria from 
homogenized hypothalamic tissue, spun at low speed, pellet was then discarded and the 
supernatant was spun at high speed. This enabled us to isolate the mitochondrial potion of the 
tissue homogenate which is the only potion used. The differences in optical density between 
oxidized and reduced forms of substrate after adding enzymes specific or shared by the 
different mitochondrial complexes. For specific complex I (CI) activity NADH: ubiquinone 
oxidoreductases (NQR) was used per units citrate synthase (CS) [205], for complex I versus 
Complex III NADH: cytochrome c reductase (NCR) [206], for complex II succinate 
dehydrogenase (SDH), for CII vs CIII succinate: cytochrome c reductase (SCR) [207] and for 
complex IV (CIV) cytochrome C oxidase (COX) [208]. All values were normalized against 
citrate synthase (CS). The limitation of this type of assay is the integrity of the samples, 
which can alter the enzymatic reactions and not reflect on the capacity of the tissue from 
where the sample originated. Example of lost integrity of the sample would include 
contamination of cellular material or additives that compromises the enzymatic activity 
before they are tested in the mitochondrial potion. 
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3.9 HPLC 
High-performance liquid chromatography (HPLC), previously called high-pressure liquid 
chromatography, is a method used to separate, identify and quantify molecules in a solution. 
We used HPLC in Paper III to analyze levels of ATP, ADP, AMP and IMP in hypothalamic 
tissue in basal condition and after one minute of ischemia as a model of stress. To test this 
two set of brains were taken one frozen immediately and one after 1 min (the ischemic 
condition). The metabolites were extracted with the use of perchloric acid and the supernatant 
containing both mitochondrial and extra-mitochondrial metabolites was analyzed with the use 
of HPLC.  To adjust for blood contamination the value from each metabolite was divided by 
total creatine. One advantage of HPLC is that several components can be analyzed in the 
same solution simultaneously. 
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4 RESULTS & DISCUSSION 
 
4.1 CONTACTIN REGULATES MYELINATION AND NODAL/PARANODAL 
ORGANIZATION IN THE CENTRAL NERVOUS SYSTEM (PAPER I)  
Previously the Ranscht lab described that the location and function of Contactin-1 expression 
in the peripheral nervous system (PNS) is restricted to the axonal potion of the paranode. 
Here it interacts in cis with Caspr, and this complex interacts with NF-155 on the myelinating 
Schwann cells in trans [59, 209]. In Paper I we evaluated the location and function of 
Contactin-1 in myelinated fast axons in the CNS.  
 
4.1.1 Contactin-1 in axon-glia interactions initiating myelination 
Documentations of Contactin-1 expression at paranodes and nodes of Ranvier of myelinated 
central nerves l [60, 210] and by developing oligodendrocytes in culture [211], was published 
before our additional data was finished. In addition to confirming those findings in Paper I 
we also show Contactin-1 expression by oligodendrocytes in vivo. By using different fixation 
and extraction methods we exposed the different locations of the Contactin-1 protein and 
labeled them with antibodies for identification of the different protein locations in the optic 
nerve at different ages. 
The IHC protocols used on the optic nerve were applied at two ages, first at P18 during active 
myelinogenesis and secondly, at P28 when mature myelin has been established [212, 213].  
In short the results can be summarized as follows: The paranodal expression is best observed 
after a longer fixation time anchoring the molecular membrane complexes and after 
extracting with methanol. The nodal expression is best observed at P28 as the region has 
matured but this area needs a longer fixation and can be subjected to methanol treatment 
without being extracted, possibly being covered by a nodal astrocyte. Finally the surrounding 
expression representing mainly oligodendrocyte membranes and myelin wraps, are best 
observed without methanol extraction as Contactin-1 is extracted with this treatment. 
Identification of the Contactin-1 expression in myelin was done by triple IHC using markers 
for oligodendrocyte progenitor cells (NG2) and mature oligodendrocytes (APC). Contactin-1 
expression coincided with loose membrane structures on oligodendrocyte precursor cells and 
downregulated when the myelin matured. At later postnatal ages (P30) only some Contactin-
1 expression remains on loose myelin membranes. These data indicated that Contactin-1 
delineates migrating, pre-myelinating and myelinating oligodendrocytes but is down 
regulated when myelin is mature. 
The role of Contactin-1 in the formation of central myelin was determined by the use of the 
Cntn1-KO mouse and comparisons of the myelin sheet specific protein myelin basic protein 
(MBP) and Gallyas myelin stain on whole brain. This revealed that without Contactin-1 there 
is a 50% reduction of MBP protein expression and a visual loss of myelin in corpus callosum. 
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This myelin loss observed in the Cntn1-KO mouse transpired into a decreased optic nerve 
diameter visualized by the cross-sections stained with a marker for mature neurofilaments, 
NF-200. When cross-sections of optic nerve were analyzed in details using electron 
micrographs a significant reduction of dense myelin profiles were found in the Cntn1-KO 
compared to the WT. 
The reduced thickness found in the optic nerve may be due to the significant reduced number 
of mature (APC positive) oligodendrocytes and the increased amount of thinner axons 
myelinated (quantified from EM).  
 
4.1.2 Contactin-1 and paranodal assembly in CNS 
As Contactin-1 was found to regulate the paranodal assembly in the peripheral nervous 
system, PNS [59], the role of paranodal assembly was investigated also in CNS using the 
optic nerve. In the CNS we saw that the potassium channel, Kv1.2, normally located in the 
juxtaparanode [214] had lost its’ defined boundary and instead relocated adjacent to the nodal 
expression of sodium channels thereby disrupting the clear separation of the two voltage 
gated channels needed for fast propagation of action potential [215, 216], the hallmark of 
myelinated axons.  
The importance of Contactin-1 for the paranodal structure was examined using electron 
micrographs of longitudinal sectioned optic nerves from the Cntn1-KO and WT. The WT 
exhibited the normal pattern with paranodal junctions where the outermost myelin loops 
closed to the nodes are attached with a junction characterized by transverse electron-dense 
bands (septate like junctions) [217, 218], however; the paranodal junctions in the optic nerve 
of the Cntn1-KO mouse were severely disrupted with myelin loops displaying overtly and 
astrocytic processes penetrating the open space between the axon and myelin membranes. 
The strongest effect from lack of Contactin-1 was a 60% reduction in appearance of bilateral 
myelin loops (myelin loops present on each side of the node of Ranvier). 
The findings of re-localization of the juxta-paranodal Kv1.2 to the intended paranode site and 
the disrupted septate- like junctions support the importance of the Contactin-1 to form and 
maintain these structures in CNS as well. 
 
4.1.3 The role of Contactin-1 in formation and maturation of the Node of 
Ranvier 
The nodal sodium channels consists of two types of subunits where alpha are the pore 
forming units regulating the electrophysiological properties of the postnatal optic nerve [219, 
220]. With the early development of the nodes and in the initial axon segment of (later to be 
myelinated) nerves sodium channel subtype Nav1.2 is expressed, featuring a lower activation 
threshold. During myelination and axonal development this subunit is in the nodes exchanged 
for a higher threshold but faster conduction Nav1.6 subunit with mature channel properties 
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and conduction characteristics [221, 222]. The effect of Contactin-1 on this developmental 
switch was investigated with IHC displaying the two populations in the optic nerves of the 
Cntn1-KO mouse vs. WT. Significant reductions were seen in the Contactin-1 mouse both in 
terms of the number of sodium channels in general and the terms of the number of mature 
Nav1.6 subunits located to the nodes. These findings can be attributed to the disrupted 
myelination caused by, the loss of Contactin-1 expression in the nodal and paranodal regions.  
 
4.1.4 Summary of Paper I 
We found strong evidence that Contactin-1 is expressed both by neurons and 
oligodendrocytes, and the location has expanded to include not only the axonal side of the 
paranode, but also the axonal node and the myelinating oligodendrocyte. Myelination is a 
complex but important process requiring many points of interactions between the axon and 
the myelinating oligodendrocytes. Contactin-1 plays an important role during the early phase 
of this communication during the postnatal myelination in the central nervous system. The 
dynamic expression of Contactin-1 is found to be essential for myelination in two ways. First, 
oligodendrocytes, although apparent in equal numbers and aligned along axons in both 
genotypes, show reduced capacity to extend membrane sheaths. This shows that Contactin-1 
is an important signal between axons and oligodendrocytes to initiate membrane sheath 
expansion and formation of myelin.  Second, Contactin-1 plays an important role in 
orchestrating the nodal/ paranodal domains in the central nervous system.  These data show 
that Contactin-1 is critical for both myelin formation and function in the CNS. 
 
4.2 COMPARATIVE STUDIES OF HYPOTHALAMIC FOOD INTAKE 
REGULATORY SYSTEMS IN ANIMAL MODELS OF ANOREXIA (PAPER II 
&IV)  
The phenotypic similarities in body weight and food intake observed between the Cntn1-KO 
and the anx/anx mouse were the promoting factors to investigate the food regulatory 
pathways in the hypothalamus of the Cntn1-KO. Previous findings in the anx/anx mouse 
showed marked changes in hypothalamic neurotransmitter and -peptidergic systems related to 
food intake regulation in these mice [38, 40, 43, 44, 223]. In Paper II we compared the 
neuropeptidergic expression in the hypothalamic systems involved in food intake regulation 
in the Cntn1-KO, the anx/anx mouse and 24hr food-deprived three weeks and in some 
instances three months old mice, by IHC and ISH.  Signs of inflammation in the 
hypothalamic systems have in several studies been associated with syndromes displaying 
phenotypes that are related do deviant energy homeostatic regulation, obesity and anorexia, 
which has been visualized with increased expression of glia specific markers and pro-
inflammatory molecules [45, 47, 51, 52, 224-233]. The anorectic anx/anx mouse has 
previously been associated with a significant increase of the microglia marker ionized Iba1 in 
a number of hypothalamic areas [45]. As a follow up study from the comparative 
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neuropeptidergic analysis in Paper II [234] we continued the comparisons by investigating 
the hypothalamic ir of an astrocytic marker, GFAP, and Iba1, in the Cntn1-KO and the 
anx/anx mouse. We also evaluated both markers in the hippocampus of the two animal 
models (Paper IV). 
 
4.2.1 Changed hypothalamic NPY and AgRP expression 
The hypothalamic expression pattern of the two orexigenic neuropeptides NPY and AgRP 
were dramatically changed in the Cntn1-KO vs. WT, resembling what is seen in the anx/anx 
mouse [40, 42].  NPY- and AgRP-ir was increased in the Arc soma, while a reduced network 
of ir-fibers projecting from these neurons to PVN was detected, in both the Cntn1-KO and the 
anx/anx mouse. These changes were however not found in the 24h food deprived mouse, 
indicating that a longer starvation period is required for the changes in distribution of the 
orexigenic neuropeptides to occur. Alternatively starvation alone will not produce such 
changes in the absence of a molecular pathology. 
ISH with NPY and AgRP mRNA specific probes revealed increased mRNA levels of the two 
peptides in both the Cntn1-KO and the anx/anx Arc neurons, correlating with the increase in 
cell body specific NPY and AgRP-ir. However, in a previous publication from Broberger et 
al (1997) [40] no differences in NPY mRNA levels in Arc of the anx/anx mouse was found. 
The discrepancy between these results is likely due to a shorter exposure time that was used 
in Paper I as longer time exposure will result in saturation of signal and loss of information. 
The ISH results of the 24hr food deprived three weeks old mice showed less of an increase, 
but still a significant increase, in NPY and AgRP mRNA, indicating that even a short period 
of food-deprivation is enough to give an up-regulation of NPY and AgRP synthesis. 
 
4.2.2 Changed hypothalamic α-MSH/ POMC expression 
α-MSH is the active peptide hormone resulting from cleavage of the POMC precursor and is 
expressed by another population of neurons in Arc [38, 235, 236]. The expression of α-MSH 
was diminished in Arc (cell bodies and fibers) and DMH (fibers) of the Cntn1-KO compared 
to WT, and the anx/anx mouse showed a resembling but not equally strong decrease. The 
24hr food deprived three weeks old mice however had accumulations of α-MSH–positive 
granules in the soma, in comparison to WT, while no significant change in the fiber 
expression was seen. The differences in POMC mRNA observed by ISH mirrored more or 
less what was seen in α-MSH peptide expressions, with diminished levels in the Cntn1-KO 
and reduced levels in the anx/anx mouse. However, the POMC mRNA level in Arc of the 
24hr food deprived mouse was also reduced. This indicates that at least after a longer period 
of starvation mice respond by reducing the expression of the anorexigenic POMC.  
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4.2.3 MCH expression in the LHA 
One innervation target for Arc NPY/AgRP expressing neurons is melanin concentrating 
hormone (MCH) positive neurons in the LHA [111]. These neurons are involved in the 
control of energy homeostasis by stimulating feeding [105, 237, 238]. In the Cntn1-KO a 
prominent reduction in MCH-ir fibers in the LHA was observed, while in the anx/anx we 
observed a small reduction in such fibers, and no change in the 24hr food deprived mice. No 
clear difference was seen in MCH-ir cell bodies in LHA in any of the models when compared 
to WT.  The MCH mRNA transcript levels were however significantly but slightly increased 
in the Cntn1-KO, while no change was seen in the anx/anx mouse of the fasted mice. 
 
4.2.4 Contactin-1 expression in the hypothalamus 
In Paper I we also showed that in WT mice, the Contactin-1 protein is expressed in a 
uniform punctate fashion in neuropil in all the hypothalamic regions evaluated (def. neuropil 
[239]) including the median eminence and Arc, correlating well with previous findings [240, 
241]. More defined, Contactin-1 was in WT found around the soma of the NPY-positive 
neurons, but was not limited to this population. The same pattern was seen in the anx/anx 
mouse. In the Cntn1-KO mouse Contactin-1 immunoreactivity (ir) was not present in 
neuropil, ir was however observed accumulated in the ER of NPY positive neurons in the 
Arc. This indicates that the NPY-neurons of the Cntn1-KO mouse likely are affected by the 
lack of functional Contactin-1. The abundant expression in the hypothalamic regions suggests 
a role for Contactin-1 in the development of these food intake-regulating systems. 
 
4.2.5 GFAP immunohistochemistry in the hypothalamus and hippocampus 
The expression of the astroglia marker GFAP was quantified by IHC and subsequent ImageJ 
analysis of the hypothalamic areas; Arc and PVN, and the dentate gyrus of the hippocampus, 
in the Cntn1-ko mouse vs. WT at age P16, and in the anx/anx mouse vs. WT at age P21. 
Image J analysis takes into account the region labeled over the region of interest. The results 
reveled no differences between the Cntn1-KO and corresponding WT in any of the areas 
(Figure 5A, B). However, the anx/anx mouse showed a significant increase of GFAP-ir fibers 
in the PVN and a trend toward elevated levels in the Arc (Figure 5C, D). The increased 
GFAP in the anx/anx mouse was supported by micro-array data from the Arc-area [36] where 
it was found up-regulated. Both Arc and PVN are areas known to be importance for 
regulating food intake [37, 242, 243]. GFAP was primarily identified as a marker for reactive 
astrocytes found in multiple sclerosis patients [244, 245], however it is not an absolute 
marker for non-reactive astrocytes but rather associated with CNS lesions [246, 247]. Thus, 
the two mouse models of anorexia show differences in reactive astrocytes in the 
hypothalamus, which points to different mechanisms for generating the anorectic phenotype. 
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4.2.6 Iba1 immunohistochemistry in the hypothalamus and hippocampus 
The increased Iba1-ir previously observed at P15 and P21 in the anx/anx mouse in both Arc 
(Figure 5G,H) and PVN [45] was not observed at P16 in the Cntn1-KO mouse (Figure 5E, F) 
indicating that a different mechanism underlies the sub sufficient energy intake in these 
models. However, the Cntn1-KO showed a significant upregulation of Iba1 in the 
hippocampal dentate gyrus area. These microglia were both bushy and rod-like indicating an 
advanced state of activation [248]. This was not mirrored in the anx/anx mouse.  
 
Figure 5. Immunofluorescence micrographs showing GFAP (A-D) and Iba1 (E-H) in Arc of the 
Cntn1-KO mouse (A, E) and WT littermate (B, F) at age P16 and the anx/anx mouse (C, G) and WT 
littermate (D, H) at age P21. 
 
4.2.7 Summary of Paper II & IV 
Paper II suggests that in comparison with the anx/anx mouse, the Cntn1-KO mouse in 
addition to becoming anorectic at a slightly younger age and emaciated faster, also display a 
stronger neuropeptidergic response to lack of food. This could suggest that different 
mechanisms are underlying the anorexia of these mice, or it is just an effect of the severity of 
the condition. This comparative study of two anorectic mouse models highlights the 
molecular complexity of timing and developmental age as the study involved two separate 
mouse strains and two different postnatal ages, however, it further solidifies the importance 
of intact hypothalamic functions as the two models despite large genetic background 
difference and slight difference in age show great similarities. The study also indicates that 
the Contactin-1 protein may be involved in the development of the hypothalamic systems 
involved in food intake. By studying the two models of anorexia in greater details one can get 
a better understanding of the hypothalamic food intake regulatory system during anorectic 
conditions, which in the end can aid in improving the treatment of anorexia nervosa. 
In addition, despite the similarities between the anx/anx and the Cntn1-KO, i.e. the anorectic 
phenotype and similar neuropeptidergic response (Paper II), there are some major 
differences between the two anorectic mouse models. The Cntn1-KO mouse has a more 
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severe phenotype compared to the anx/anx mouse, i.e. the weight reduction starts earlier and 
progresses more rapidly [32, 249] despite given assisted feeding twice daily. Moreover, the 
Cntn1-KO displays a very strong ataxic phenotype, which together with the decreased 
myelination possibly leads to increased energy needs [127] and significantly reduces the 
ability to be breastfeed. The up-regulation of a astrocyte-marker and a microglia-marker in 
the hypothalamus of the anx/anx mouse (Paper IV) [45], could be related to signs of 
neurodegeneration [47] and  mitochondrial dysfunction leading to increased ROS production 
[46, 47], both documented previously. Another possibility is that the up-regulation of glia 
markers in anx/anx is related to increased serum levels of free fatty acids [250] due to excess 
breakdown of fat observed in anorectic conditions [251-254]. FFA can stimulate 
hypothalamic inflammation [255]. The serum levels of FFA have not been analyzed in the 
Cntn1-KO mouse. However, we didn’t find up-regulation of neither GFAP nor Iba1 in the 
hypothalamic regions of Arc and PVN in the Cntn1-KO mouse, indicating that the 
neuropeptidergic changes previously observed in the hypothalamus (Paper II) might be a 
developmental defect rather than degeneration. A developmental defect in the Arc to PVN 
projection regulated by Contactin-1 could be due to misguided axonal outgrowth [31, 65] or 
synaptic plasticity [76, 256]. However, Iba1-ir labeling indicating activated microglia was 
seen both in highly ramified and phagocytic stage was found in the hippocampal region of 
dentate gyrus in the Cntn1-KO which could be related to synaptic plasticity defects 
previously found in the Cntn1-KO mouse [76]. 
 
4.3 REDUCED HYPOTHALAMIC METABOLISM IN THE ANX/ANX MOUSE 
(PAPER III)  
We hypothesize that the anorectic anx/anx mouse which has a documented mitochondrial 
dysfunction, leading to increased reactive oxygen species (ROS) production and possibly 
lower ATP in the hypothalamic Arc, may result in a detrimental effect on the cellular 
metabolism and resulting reduced neuronal activity. The food regulatory areas of the 
hypothalamus have an increased expression of a specific subtype of the ATP-sensitive 
potassium channels, KATP required for generating an action potential, making these cells (both 
neurons and glia cells) more sensitive to changes in energy levels and ROS [148, 257, 258]. 
In Paper III we therefore explored the hypothalamic metabolism of the anx/anx mouse. 
 
4.3.1 Enzymatic activity of the respiratory chain subunits in the anx/anx 
hypothalamus 
Evaluation of the enzymatic activity of the complexes in the mitochondrial oxidative 
phosphorylation system after normalization to citrate synthase revealed significant reductions 
in activity was seen in complex I (CI), and in the dual assay covering both complex I and 
complex III (CIII). CIII is linked to CI [259], and its’ function is distinguished by measuring 
CI separate and then measure the combination of CI and CIII and subtracting the CI specific 
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function. The enzymatic activity observed in Complex II and IV showed no significant 
changes between the anx/anx mouse and WT. CS is a pace maker enzyme regulating the first 
step of the tricarboxylic acid (TCA) cycle and used as a marker of the amount of 
mitochondria used. Since no differences was seen in this enzyme in the anx/anx mouse 
compared to the WT mouse the changes seen are not due to a difference in number of 
mitochondria. These results confirm previous findings showing CI dysfunction being related 
to the anorexia of the anx/anx mouse [36]. 
 
4.3.2 Glucose transporters and AMPK activation in the anx/anx 
hypothalamus 
We detected increased protein levels of 5' AMP-activated protein kinase (AMPK) and insulin 
independent glucose transporter 4 (Glut4) in isolated hypothalamic tissue, from the anx/anx 
mouse vs. WT. AMPK is acting like a metabolic master switch sensing the cellular levels of 
AMP. AMP levels increases during energy deficiency, like hypoxia, ischemia and glucose 
deprivation, and this leads to activation of AMPK by phosphorylation into AMPK-P. This 
activation results in translocating the normally intracellular located Glut4 to the extracellular 
portion of the membrane, thereby facilitating glucose transport into the cell and increasing 
cellular energy levels [260, 261]. This pattern of increase is previously observed in tissue as a 
response to increased metabolic stress such as exercise [262]. To supply for an increased 
energy demand activated AMPK are involved in the biogenesis of more mitochondria and 
increased synthesis of Glut4 [263]. The findings at basal state from the anx/anx mouse 
indicates a significant reduction of activated AMPK and when AMPK-P is taken as the ratio 
of total AMPK the lower value is consistent with a lower metabolic stress and correlates well 
with some sort of adaptation to starvation or hibernation [264]. This is further observed in 
Alzheimer’s disease where it reflects lower neuronal activity [265, 266]. 
 
4.3.3 A hypometabolic state in the anx/anx hypothalamus 
Metabolic stress often accompanies conditions involving mitochondrial dysfunction. In order 
to ensure sufficient ATP levels in such situations, phosphocreatine (PCr) levels are often 
depleted (since they have donated a phosphate group to ADP), lactate elevated (a by-product 
from increased glycolysis) and glucose uptake increased [89-91]. By observing the levels of 
specific metabolites we were able to study the cellular metabolism at basal level and after 
ischemic stress in the anorectic anx/anx mouse vs WT. At basal metabolic level the anx/anx 
mouse and WT had similar metabolic turnover of ATP and glucose-6 phosphate, PCr was 
however higher indicating that less of this metabolite donated a phosphate group to ADP in 
order to restore ATP in the anx/anx compared to WT. Lactate was lower in anx/anx 
compared to WT hypothalamus, thus indicating lower glycolysis. However, what is 
interesting is how the cells react under stress in this case ischemia. We found that after 
ischemia, both ATP and PCr were significantly higher while lactate was still lower in the 
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anx/anx mouse compared to WT. These changes indicate that the anx/anx mouse utilizes less 
energy despite having more energy stored in the forms of phosphorylation donors like the 
PCr. It also indicates that the anx/anx mouse generated more ATP from PCr 
dephosphorylation and less from glycolysis via lactate production, and overall the ATP 
turnover was 10% reduced in the anorectic mouse model. The latter was supported by 
detection of reduced levels of AMP and IMP in ischemia. AMP and IMP can be considered 
by-products from ATP utilization, and lower levels, thus indicates lower usage of ATP. 
Taken together the results indicate a hypometabolic state of the anx/anx hypothalamus, both 
during basal and ischemic conditions.  
 
4.3.4 Reduced glucose uptake in the anx/anx hypothalamus 
By autoradiography we detected reduced uptake of glucose in the hypothalamus of the 
anx/anx mouse, which would indicate a less metabolically active system. The radioactive 3H-
glucose injected in this experiment is DD-glucose which functions differently from regular 
glucose in terms of being metabolically inactive, it will thus not play a role in glycolysis and 
thus not any active role as energy source [201]. It will however be transported inside cells 
like regular glucose but will remain stationary within the cell. The 3H-DD-glucose will 
therefore provide a measurement of glucose uptake, however, only the innate glucose will be 
utilized by the cells/neurons. Despite normal levels of Glut1 and increased levels of Glut4 in 
the hypothalamic areas the anx/anx mouse had a significantly reduced hypothalamic glucose 
uptake, which suggest a form of hypometabolism.  
 
4.3.5 Summary of Paper III 
In response to elevated energy demands a normal system usually responds with increased 
metabolic stress by increased expression of AMPK-total and Glut4 and an increased glucose 
uptake and increased ATP turnover [262].  However, the anx/anx mouse displays a different 
scenario where elevated levels of AMPK-total and Glut4 are accompanied with hypo-
metabolism and unused energy resources left inside the cells (increased ATP and 
phosphocreatine after ischemia). The mechanism behind this is not fully understood. 
However, this reduced response to stress (induced by ischemia) observed in the anx/anx 
mouse may be a result of an adaption to long-term starvation and/or mitochondrial 
dysfunction and may correspond to a type of metabolic depression observed during 
hibernation [264, 267]. 
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5 CONCLUSION AND HYPOTHESIS 
This thesis includes CNS studies that started with investigations of the molecular interactions 
involved in myelination and functional compartmentalization of nerves (Paper I) in relation 
to the cell adhesion molecule Contactin-1, and continued with the explorations of the 
anorectic and hypothalamic phenotype of the Cntn1-KO mouse in comparison to the anx/anx 
mouse (Paper II and IV). These studies show that the two mouse models have many 
similarities in expression of hypothalamic neuropeptides important for food intake regulation 
(Paper II), but also differences in expression of markers of glia cells in the same 
hypothalamic system (Paper IV). Based on previous findings associating the anorectic 
phenotype of the anx/anx mouse with a mitochondrial dysfunction [36] we explored the 
possibility that this results in putting the hypothalamic neurons in a hibernation state and in 
fact found that a reduced hypothalamic metabolic activity was involved (Paper IV). We 
believe that this hibernation could be a contributing factor to the signs of degeneration also 
documented in this mouse [46, 47], in the sense that a prolonged hibernation/inactivation 
leads to among others reduced levels of neurotrophic factors and a sign that these neurons or 
at least some of their projections should be cleared away. 
In regard to the functions of Contactin-1 in myelinated axons (Paper I), patients with MS are 
living proofs that the interaction between axons and oligodendrocytes are of essence. A better 
understanding of the molecular signals regulating the myelination process is beneficial for 
understanding how myelin can be rebuilt. With the help of the Cntn1-KO isolated optic nerve 
we have highlighted the importance of Contactin-1 in axon-glia communication during later 
stages of myelination, and also in the formation and maturation of axonal domains. There is a 
dynamic expression of Contactin-1 on axons and oligodendrocytes essential for CNS 
myelination. The myelination process starts with precursor cells migrating to selected axons. 
There they proliferate and mature before the actual myelination or wrapping occurs. 
Contactin-1 plays a role in the later part of this sequence regulating oligodendrocyte 
differentiation and expansion of the wraps. A hypothesis regarding how Contactin-1 protein 
expressed by oligodendrocytes regulates the wrapping involves Src-related kinases that 
increase the expression of MBP in oligodendrocyte processes [268-270]. In addition, 
Contactin-1 is involved in the maturation of the axons shown by the significantly thinner 
optic nerve axons in the Cntn1-KO mouse. The maturation of axons depends on their activity, 
which induces synapse formation and target innervation, and from oligodendrocyte signals 
and intrinsic factors. Since target innervation occurs in the optic nerve in the Cntn1-KO 
mouse, the intrinsic and oligodendrocyte signals remain to be considered. Contactin-1 
interacts with several other cell-surface molecules that may primarily or secondarily regulate 
the cellular mechanisms needed for axon maturation [60, 271-274]. Another explanation for 
the reduced axonal thickness, in the Cntn1-KO mouse, may be that the smaller diameter 
axons have a reduced axon-glia signaling needed for maturation of the axons and/or that the 
glia Contactin-1 protein expression regulate axon maturation [275].  
For axons to propagate signals efficiently, the myelin needs to be organized into separate 
domains so that myelin segments are interspersed by nodes of Ranvier harboring clusters of 
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sodium channels. The paranodal junctions are segregating the nodal sodium channels form 
the juxtaparanodal potassium channels underneath the myelin [276, 277]. In the PNS, 
Contactin-1 is restricted to the axon membrane in the paranodal region [59]. Myelin-forming 
Schwann cells do not express Contactin-1 and no myelin loss is observed in peripheral nerves 
of Cntn1-KO mice. Similarly, when only the paranodal junction is disrupted in the CNS, as in 
Caspr-KO mice, the myelin wraps remains intact [278].  These data show that paranodal 
junctions are not needed for myelin formation but are critical for the domain organization of 
myelinated nerve in both the CNS and PNS [279-281]. Contactin-1 expression in the 
paranodal region in both PNS and CNS is important to regulate formation of the paranodal 
septate-like junctions that are critical for the function but not for the formation of myelin.  
The functions of Contactin-1 at the central (but not peripheral) nodes of Ranvier are 
associated with the level of sodium channel surface expression and the switch from the early 
Nav1.2 to the mature and faster Nav 1.6 pore forming subunits (Paper I). Possible 
mechanism is direct interactions of Contactin-1 with the non-pore forming sodium channel 
ß1-subunit [58, 60] that influences the number of sodium channels expressed on axon 
surface. Numbers of sodium channels, in turn, regulate neuronal electrical activity and a 
reduced compound action potential was observed in the Cntn1-KO [60]. Although such a 
mechanism could contribute to the observed myelin phenotype, a more likely interpretation is 
that loss of paranodal septate-like junctions in Cntn1-KO mice prevents efficient clustering 
and maturation of sodium channel clusters and thus lead to their reduction in number and 
poor maturation 
In conclusion, Contactin-1 in myelinated nerves in the CNS (Paper I) plays important and 
separate roles during early and late development of myelinated nerves. As an early signal 
Contactin-1 regulates axon maturation and initiation of myelination in the CNS. At later 
stages Contactin-1 orchestrates the formation of nodal and paranodal domains and the 
formation of the paranodal axon-glial junctions. Knowledge about how a system is generated 
and functions forms an important basis towards approaches aimed at regeneration after 
degeneration has occurred. This is highly significant in studies regarding myelin degenerative 
disease such as multiple sclerosis.  
The Cntn1-KO mouse exhibit other prominent phenotypes besides the loss of function in fast 
propagating axons, it also develop severe anorexia and ataxia. The ataxia is related to the 
cerebellar defect previously described [249]. The anorectic phenotype was explored in this 
thesis (Paper II and IV) by the use of comparative studies with the already established 
anorectic anx/anx mouse and a 24hr fasted mouse.  Investigating the expression levels and 
location of the neuropeptides regulating increase of food intake, the orexigenic NPY/ AgRP 
neuropeptides originating in Arc, we found that the mRNA levels were upregulated in the 
Cntn1-KO mouse, the anx/anx mouse and the food deprived mouse. This can be seen as a 
normal compensatory response to reduced food intake. However, the most pronounced 
changes are found in the most emaciated anorectic mouse model, the Cntn1-KO mouse. The 
cellular location of these orexigenic neuropeptides as seen by IHC, was further disrupted with 
what looked like accumulation of the peptides in the neuronal cell bodies, and reduced levels 
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in the neuronal fibers projecting to the PVN. To be noted is that the neuronal projections from 
Arc to PVN target are not fully mature until the third postnatal week [110, 282] and therefore 
the dramatic cellular changes observed in the Cntn1-KO may reflect an inability to regulate 
axon outgrowth as has been observed in the cerebellum [249]. Interestingly, a similar 
reduction in axonal outgrowth has been associated with obesity both in leptin deficient mice 
[283, 284] and mice with monosodium glutamate lesions of the Arc [285]. The outcome, 
obesity vs anorexia, of hampered axonal Arc-PVN outgrowth, may thus reside within the 
functionality of the other Arc population, the POMC/CART neurons. It is also possible that 
the obese vs anorectic phenotype is rather a result of that once the Arc-PVN 
neurotransmission is weakened, the activity in other regions, such as regions involved in 
reward aspects of food intake, are allowed to become more prominent.   
Another possible explanation to the change in neuropeptidergic expression seen by IHC in 
the Cntn1-KO is that the axons are still present but in the absence of Contactin-1 a transport 
defect may result in loss of NPY and AgRP-ir in fibers. Contactin-1 has previously been 
associated with transporting associated proteins to the cell surface as with Caspr [59, 76] and 
sodium channels [60]. The latter which will further lead to alterations in the 
electrophysiological activity of the axons which in turn could lead to modifications of the 
responsiveness to food intake regulatory signaling. However, considering later data from the 
second comparative study between the Cntn1-KO mouse and the anx/anx mouse (Paper IV) 
neither the transport hypothesis nor the axonal activity may be valid as inactive axons would 
be pruned away and degenerative processes would take place. Degenerative processes in the 
brain are associated with increased expression of GFAP positive astrocytes and Iba1 positive 
microglia [286, 287]. Increased Iba1-ir cells were found in several hypothalamic regions of 
the anx/anx mouse [45]. Increased GFAP-ir was also seen in the hypothalamus of these mice 
The Cntn1-KO mouse did not however show any increased GFAP- or Iba1-ir in the 
hypothalamic areas thus far evaluated; Arc and PVN. More hypothalamic regions will 
however be analyzed, including the MPO. These data do nevertheless suggest that there is no 
inflammatory response in the hypothalamus of the Cntn1-KO mouse. In contrast to the 
hypothalamus expression, the dental gyrus of the hippocampus did exhibit increased 
expression of the microglia marker, but showed no change for the astrocyte marker. These 
results indicate that the Cntn1-KO may not be compromised by a dysfunctional immune 
response in the CNS. The reason for the increase Iba1-ir could be related to the synaptic 
defects previously found in the hippocampal CA1 region of the Cntn1-KO [76]. It could also 
be related to the distorted food intake maybe via the “hunger hormone” ghrelin signaling 
regulating firing of hippocampal neurons [288] or by secondary hypothalamic projections 
from the PVN to the different hippocampal areas [289]. No hippocampal increase in glia 
markers was observed in the anx/anx mouse (Paper IV), despite previous studies showing 
increased cell proliferation and apoptosis in the dentate gyrus of the anx/anx mouse by Kim et 
al. [54].  
The mitochondrial dysfunction (the main producer of cellular ATP) found in the anx/anx 
mouse may play a crucial role in regulating the activity level of the Arc neurons as they are 
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expressing a specific subtype of the ATP sensitive potassium channels, Kir6.2/SUR1, 
regulating the activity levels of the neurons depending on the ATP levels [290, 291]. To test 
whether the mitochondrial dysfunction in the anx/anx mouse results in a reduced activity 
level of the Arc neurons which in turn would lead to reduced firing potential and a 
dysfunctional regulation of food intake, the metabolic activity was tested (Paper IV). A 
dysfunction of the mitochondrial ATP producing oxidative phosphorylation system normally 
generates less ATP and to compensate for this reduction, the cells increase the glucose 
uptake, increase glycolysis and PCr is reduced since it donates a phosphate to ADP in order 
to generate ATP. However, in the anorectic anx/anx mouse we observed a reduced glucose 
uptake despite a compensatory up-regulation of the glucose transporter Glut4 but a decreased 
ratio of the AMPK-P/AMPK indicates no translocation of the glucose transporter. The 
elevated levels of PCr both at basal level and during stress, indicates that the hypothalamic 
neurons of the anx/anx mouse have an excess of phosphate donors to generate ATP. The 
decreased levels of lactate indicates that, despite the mitochondrial dysfunction generating 
less ATP, the anaerobic glycolysis is not utilized, via pyruvate, to generate more energy.  The 
reduced uptake of glucose together with reduced levels of cellular AMP and IMP and 
increased level of ATP in the anx/anx mouse points to that hypothalamic neurons are utilizing 
less energy and therefore are less active. We did not isolate each cellular type of the 
hypothalamus when the metabolic activity within the cells were measured and cannot 
determine the ATP source nor which cell type in the hypothalamus that suffer most from 
reduced cellular metabolism. The astrocytes regulate synaptic activity of the hypothalamic 
neurons [292, 293].  
To self starve requires extreme determination and most people will start to eat due to very 
strong hunger senses, as an evolutionary safeguard against too low energy reserves 
(represented by low levels of leptin and insulin and high levels of ghrelin).  However, what if 
there is genetic errors preventing the neurons to signal normally and starvation can prolong 
and even feel as a reward or at least some type of satisfaction? What if you are born with 
reduced hunger feelings long before body appearance is considered? These two questions are 
central for our studies in the hypothalamus of the two anorectic mouse models. The 
predisposition to AN is most likely caused by several genes, therefore, reduced cellular 
metabolic activity and glia activation related to mitochondrial dysfunction in the anx/anx 
mouse and neuropeptidergic changes in the Cntn-1 KO mouse may be applicatory genetic 
causes to human adolescents with AN and with kids with failure to thrive. In regards to AN 
there may be environmental factors that trigger the onset, however, it failure to thrive the 
environmental factor may not be as strong as the genetic factor as this may start even in 
infants. The two anorectic mouse models in our studies represent a pure genetic adolescent 
model of AN.  
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6 FUTURE PERSPECTIVES 
In order to further understand the molecular mechanism whereby Contactin-1 modulates 
hypothalamic NPY/AgRP neurons it would be of value to further explore if/how Contactin-1 
affects axonal outgrowth of the Arc projections to the PVN target. This can be done using 
explant cultures from the Arc and PVN of Cntn1-KO and WT mice, and further with DiI 
labeling of Arc neurons tracing the axonal outgrowth in situ in fixed tissue. Another option is 
to analyze the Cntn1-KO mouse crossed with the NPY-GFP mouse to monitor the axons by 
green fluorescent protein expressed from the NPY promotor.  With the analysis of Contactin-
1 and Caspr-1 expression levels and location in the anx/anx mouse we will be able under 
stand more of the function of Contactin-1 in the hypothalamus and further tease out the 
molecular differences between the two anorectic mouse models. Contactin-1 has been found 
to interact with the chondroitin sulfate proteoglycan phosphacan/receptor-type protein 
tyrosine phosphatase beta, RPPT-ß, expressed by astrocytes and on nerve fibers around 
neurons in the PVN target area. A possible mechanism is that this interaction is involved in 
modulating the synaptic plasticity of the Arc neurons [294] or to shuttle lactate to neurons for 
increased ATP production [295]. To investigate if functional synapses are formed in the 
target area we will use synaptic markers identifying pre- and postsynaptic structures.  
Further analyses of glial expression in other hypothalamic areas of the Cntn1-KO are needed. 
This,  since the strongest increase in expression of the microglia marker observed in the 
anx/anx mouse was in the MPO [45]. Continuing studies on the anx/anx mouse would 
include anti-inflammatory treatments in order to investigate the role of the inflammatory 
profile on the anorectic phenotype, i.e. studying possible improvements in survival, body 
weight, food intake as well as possible modulation of the observed hypothalamic activation of 
microglia. Since we confirmed that there is reduced cellular metabolic activity in the 
hypothalamus of the anx/anx mouse, we need to investigate which cell type is mostly affected 
by the mitochondrial dysfunction. This would be done by investigating levels of AMPK-(P) 
in astrocytes and neurons separately.  Cortical astrocytes and neurons have an equal amount 
of mitochondria but have cell type specific pattern for key glycolytic enzymes as astrocytes 
favor a higher glycolytic rate and lower oxidative metabolism and neurons favor the opposite 
[296, 297]. Since astrocytes are involved in the support of normal neuronal process activity it 
is possible that a lack of this function will promote degeneration of neurons in the 
hypothalamus.  
Finally, the expression pattern of KATP in the anx/anx mouse should be studied in detail, since 
we suggest that the expression of KATP with the specific pore-forming subunits Kir6.2 and 
regulatory SUR1 by the Arc neurons makes these neurons extra sensitive to ATP deficiency 
and increased levels of ROS, and thus put them in a hibernation-like state [148, 257, 258, 
298, 299]. The KATP expression could be associated with anorexia in the Cntn1-KO mouse as 
well, as the maturation of the NPY/AgRP projections have been associated with initiation of 
KATP (Kir6.2/SUR1) expression and nutritional status [298]. It would thus be worth exploring 
the channel in these animals as well as in humans with AN.  
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